DENVER – The International Association for the Study of Lung Cancer (IASLC) invites patient advocates to apply for the organization's Advocacy Travel Awards. The IASLC will offer travel awards to a limited number of patient advocates to participate in the World Conference on Lung Cancer (WCLC) Oct. 27-30, 2013 in Sydney, Australia. Awardees receive free conference registration, up to four nights' accommodations, a free IASLC Membership and a cash award for 1,000 AUD.

April 2013

The World Conference on Lung Cancer in Sydney is coming closer, October 27-30, 2013. A very exciting program has been established by the program committee and particularly the two Conference Presidents, Drs. Michael Boyer and Kwun Fong. Please note that the deadline for abstract is June 21, 2013 and we hope as many members as possible will submit abstracts. The IASLC would like to draw your attention to the special travel awards offered to the patient’s advocates.

A significant step towards implementation of personalized medicine for lung cancer patients is the recent publication of the CAP/IASLC/AMP Guidelines for Molecular Testing. The IASLC is proud to be a part of this development, which should improve patient care and secure the many patients with lung cancer the most optimal therapy based on standardized and validated molecular tests. The IASLC is currently putting considerable effort into implementing these guidelines in clinical practice.

February 2013

We hope all of you enjoyed good holidays and are now ready for a productive 2013 IASLC year!

The World Conference in Sydney is approaching soon, and abstract submission is now open. Embedded in the program are many educational activities for younger colleagues, together with the scientific program.

December 2012

As most of us are approaching the holidays, the IASLC is continuing the many activities. The deadline for the new IASLC Fellowship program is January 16, 2013. We encourage as many as possible to apply for this great opportunity.

The Heine H. Hansen fellowships were launched in celebration of the IASLC 40th year anniversary. We hope many of the IASLC members will support this effort to stimulate career development for the next generation lung cancer investigators!

DENVER – The International Association for the Study of Lung Cancer (IASLC) has named Alex A. Adjei, MD;PhD;FACP, the new Editor-in-Chief of the Journal of Thoracic Oncology (JTO). Dr Adjei, Professor and Chair of the Department of Medicine and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park Cancer Institute in Buffalo, New York, takes over January 1, 2013 from Dr. James Jett who has been the Editor of the journal since its launch in 2006.

DENVER – Since 1995, November has been recognized as Lung Cancer Awareness Month in the United States. Lung cancer is the number one cancer killer of both men and women in the U.S., claiming more than 160,000 victims each year in the U.S. alone. It kills more people than breast, prostate, colon, liver, kidney and melanoma cancers combined.